Ronald Blue & Co’s Merck MRK Stock Holding History

Ronald Blue & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$215K	Buy	+3,507	New	+$213K	0.01%	199
2016 Q2	–	Sell	-4,812	Closed	-$243K	–	238
2016 Q1	$243K	Sell	4,812 -2,264	-32%	-$111K	0.01%	159
2015 Q4	$357K	Sell	7,076 -10,408	-60%	-$525K	0.02%	118
2015 Q3	$824K	Sell	17,484 -3,617	-17%	-$192K	0.04%	91
2015 Q2	$1.15M	Buy	21,101 +497	+2%	+$27.9K	0.05%	73
2015 Q1	$1.13M	Sell	20,604 -5,067	-20%	-$287K	0.05%	72
2014 Q4	$1.39M	Buy	25,671 +356	+1%	+$19.8K	0.07%	64
2014 Q3	$1.43M	Sell	25,315 -1,706	-6%	-$95.8K	0.09%	55
2014 Q2	$1.49M	Buy	27,021 +153	+0.6%	+$8.35K	0.09%	52
2014 Q1	$1.46M	Sell	26,868 -1,134	-4%	-$58.7K	0.11%	52
2013 Q4	$1.34M	Buy	28,002 +1,816	+7%	+$83K	0.1%	64
2013 Q3	$1.19M	Buy	26,186 +24,209	+1,225%	+$1.11M	0.1%	57
2013 Q2	$88K	Buy	+1,977	New	+$88.3K	0.01%	167

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ronald Blue & Co's MRK Position: Q2 2017 in Review

Ronald Blue & Co opened a new position in Merck (MRK) in Q2 2017: 3,507 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #199 among its holdings. This is a return to the name: Ronald Blue & Co previously reported a position in MRK as recently as Q1 2016.

Ronald Blue & Co first reported a position in MRK in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.49M in Q2 2014. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

Ronald Blue & Co held 3,507 shares of Merck worth $215K as of Q2 2017.
Merck was a new Ronald Blue & Co position in Q2 2017.
Merck made up 0.01% of Ronald Blue & Co's portfolio in Q2 2017, its #199 holding.
Ronald Blue & Co first reported a position in Merck in Q2 2013 and has held it in 13 quarters since.
Ronald Blue & Co's Merck position peaked at $1.49M in Q2 2014.
1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.